NYSE: Corporate Board Member Online
Mitigating the Risks of Stockholder Litigation in M&A Transactions
July 31, 2015
The statistics are remarkable. Virtually every merger transaction nowadays involving a public company will be the subject of stockholder litigation. That is true regardless of the size of the deal, the size of the premium, the form of the transaction, the identity of the parties or the care with which the board proceeded. Often, plaintiffs' firms announce “investigations” of transactions within a matter of hours of the announcement of a transaction—and sometimes within minutes. Given the near certainty that your deal will be the subject of litigation, this article provides a few common sense ways to mitigate exposure and to ensure that the inevitable lawsuits result in minimal disruption.
Contacts
Capabilities
Suggested News & Insights
Sidley Represents Sensei Biotherapeutics in Acquisition of Faeth TherapeuticsFebruary 18, 2026Sidley Represents Cherokee Nation Businesses in Its Investment in Front Line Power ConstructionFebruary 18, 2026Sidley Represents Arsenal Capital Partners and MaxHealth in Sale of MaxHealth to CenterWellFebruary 17, 2026Sidley Shortlisted for Deal of the Year and Attorney of the Year at D CEO Mergers & Acquisition Awards 2026February 17, 2026Sidley Represents New Catalyst in Strategic Partnership With Ferghana Investment PartnersFebruary 11, 2026Sidley Represents Great Lakes In Its US$1.5 Billion Acquisition by SaltchukFebruary 11, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
